Xizang Haisco Pharmaceutical Group invested $10 million in Israeli medical device maker Endospan, a company that makes aortic stents. With the investment, Haisco obtained China rights to Endospan's two devices: the Nexus™, which repairs damage to the aortic arch, and the Horizon™, which repairs abdominal aortic aneurysms. Endoscan, which raised $25 million in the funding, says its devices are less invasive than the competition.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
